UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2018

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from______________ to _______________

 

Commission File No. 000-49654

 

CirTran Corporation
(Exact name of registrant as specified in its charter)

 

Nevada   68-0121636
(State or other jurisdiction
of incorporation or organization)
 

(IRS Employer

Identification No.)

 

4125 South 6000 West, West Valley City, Utah 84128
(Address of principal executive offices and zip code)
 
(801) 963-5112
(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Accelerated filer [  ]
Non-accelerated filer [  ] Smaller reporting company [X]
Emerging growth company [  ]  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes [  ] No [X]

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of November 6, 2018, there were 4,498,891,910 shares of common stock, $0.001 par value, outstanding.

 

 

 

   
 

 

CirTran Corporation

Form 10-Q for the Three and Nine Months Ended September 30, 2018

 

TABLE OF CONTENTS

 

Item   Page
  Part I—Financial Information  
     
1 Financial Statements (Unaudited) 3
  Balance Sheets 3
  Statements of Operations 4
  Statements of Cash Flows 5
  Notes to the Financial Statements 6
2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
3 Quantitative and Qualitative Disclosures about Market Risk 23
4 Controls and Procedures 23
     
  Part II—Other Information  
     
6 Exhibits 24
  Signatures 25

 

 2 
 

 

PART I–FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CIRTRAN CORPORATION

CONSOLIDATED BALANCE SHEETS

 

   September 30, 2018   December 31, 2017 
   (unaudited)     
ASSETS        
         
Current assets          
Cash  $18,564   $5,824 
Other current assets   -    347 
Assets from discontinued operations   122    62 
Total current assets   18,686    6,233 
           
Investment in securities at cost   300,000    300,000 
Property and equipment, net of accumulated depreciation   12,638    14,357 
           
Total assets  $331,324   $320,590 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
Current liabilities          
Accounts payable  $2,068,334   $2,217,329 
Related party payable   3,000    8,548 
Short-term advances payable   44,506    44,506 
Short-term advances payable - related parties   831,871    520,608 
Accrued liabilities   716,186    729,384 
Accrued payroll and compensation expense   4,202,033    4,153,237 
Accrued interest, current portion   1,929,570    1,644,719 
Deferred revenue   -    638 
Convertible debenture, current portion   200,000    200,000 
Note payable, current portion   90,000    90,000 
Note payable to stockholders and members   151,833    151,833 
Liabilities from discontinued operations   26,114,345    25,996,119 
Total current liabilities   36,351,678    35,756,921 
           
Accrued interest, net of current portion   1,221,443    1,137,325 
Note payable, net of current portion   500,000    500,000 
Convertible debenture, net of current portion   2,390,528    2,390,528 
Total liabilities   40,463,649    39,784,774 
           
Stockholders’ deficit          
Common stock, par value $0.001; 4,500,000,000 shares authorized; 4,498,891,910 shares issued and outstanding   4,498,892    4,498,892 
Additional paid in capital   32,728,223    32,636,223 
Accumulated deficit   (77,359,440)   (76,599,299)
Total stockholders’ deficit   (40,132,325)   (39,464,184)
           
Total liabilities and stockholders’ deficit  $331,324   $320,590 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 3 
 

 

CIRTRAN CORPORATION

UNAUDITED CONSOLDIATED STATEMENT OF OPERATIONS

 

   Three Months Ended September 30,  Nine months ended September 30,
   2018   2017   2018   2017 
Net sales  $-   $5,000   $-   $5,000 
Cost of sales   -    -    -    - 
Gross profit   -    5,000    -    5,000 
                     
Operating expenses                    
Selling, general and administrative expenses   105,068    91,155    286,544    577,095 
Total operating expenses   105,068    91,155    286,544    577,095 
                     
Loss from operations   (105,068)   (86,155)   (286,544)   (572,095)
                     
Other income (expense)                    
Interest expense   (120,004)   (120,940)   (373,056)   (361,639)
Loss on derivative valuation   -    -    -    (8,456)
Other income   22,500    -    22,500    - 
Loss on settlement of debt   -    -    -    (500,000)
Total other income (expense)   (97,504)   (120,940)   (350,556)   (870,095)
                     
Net loss from continuing operations   (202,572)   (207,095)   (637,100)   (1,442,190)
                     
Loss from discontinued operations   (38,681)   (64,194)   (123,041)   (355,852)
                     
Net loss  $(241,253)  $(271,289)  $(760,141)  $(1,798,042)
                     
Net loss from discontinued operations per common share, basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
Loss per common share, basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
Basic and diluted weighted average common shares outstanding   4,489,891,910    4,489,891,910    4,489,891,910    4,489,891,910 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 4 
 

 

CIRTRAN CORPORATION

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   Nine Months ended September 30, 
   2018   2017 
Cash flows from operating activities          
Net loss from continuing operations  $(637,100)  $(1,442,190)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities          
Depreciation expense   1,719    1,719 
Expenses paid on behalf of Company by a related party   395,323    79,300 
Loss on derivative fair value adjustment   -    8,456 
Loss on settlement of debt   -    500,000 
Changes in operating assets and liabilities:          
Other current assets   347    26,132 
Accounts payable   (148,995)   278,289 
Related party payable   (5,548)     
Accrued liabilities   (13,198)   (20,187)
Accrued payroll and compensation   48,796    119,698 
Accrued interest   368,969    361,575 
Deferred revenue   (638)   - 
Net cash used in continuing operating activities   9,675    (87,208)
Net cash provided by discontinued operations   (4,875)   (12,580)
Net cash provided by (used in) operating activities   4,800    (99,788)
           
Cash flows from financing activities          
Bank overdraft   -    (2,620)
Proceeds from related party loans   58,415    176,128 
Repayments of related party loans   (50,475)   (184,363)
Proceeds from loans payable   -    200,000 
Cash provided by financing activities   7,940    189,145 
Cash used in discontinued financing activities   -    - 
Net cash provided by financing activities   7,940    189,145 
           
           
Net change in cash   12,740    89,357 
Cash, beginning of period   5,824    273 
Cash, end of period  $18,564   $89,630 
           
Supplemental disclosure of cash flow information          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 
           
Supplemental disclosure of non-cash investing activities          
Forgiveness of related party loan  $92,000   $- 
Write off of derivative liability to additional paid in capital  $-   $3,407,053 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 5 
 

 

CIRTRAN CORPORATION

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

 

NOTE 1—BASIS OF PRESENTATION

 

The consolidated financial statements of Cirtran Corporation for the three- and nine-month periods ended September 30, 2018 and 2017, are not audited. Our consolidated financial statements are prepared in accordance with the requirements for unaudited interim periods and, consequently, do not include all disclosures required to be made in conformity with accounting principles generally accepted in the United States of America. In the opinion of our management, the accompanying consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of September 30, 2018, and December 31, 2017, and our results of operations and cash flows for the periods ended September 30, 2018 and 2017. The results of operations for the three and nine months ended September 30, 2018 and 2017, are not necessarily indicative of the results for a full-year period. These interim consolidated financial statements should be read in conjunction with the financial statements included in our registration statement on Form 10/A filed on June 27, 2018, with the Securities and Exchange Commission, which became effective on July 2, 2018.

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

We consolidate all of our majority-owned subsidiaries, companies over which we exercise control through majority voting rights, and companies in which we have a variable interest and we are the primary beneficiary. We account for our investments in common stock of other companies that we do not control, but over which we can exert significant influence using the cost method.

 

The consolidated financial statements include the accounts of CirTran Corporation and our wholly owned subsidiaries: CirTran Beverage Corp., CirTran Products Corp., CirTran Online Corp., CirTran Media Corp., CirTran Corporation (Utah), CirTran - Asia, Inc., and Racore Network, Inc. All intercompany balances and transactions have been eliminated.

 

Use of Estimates

 

In preparing the financial statements in accordance with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.

 

Revenue Recognition

 

We follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, the for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial statements. We recognize revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to be received in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Revenue is recognized when products are shipped, title passes to the customer or independent sales representative at the time of shipment, the price is fixed and determinable, and collectability of revenue is reasonably assured. Returns for defective items are either repaired and sent back to the customer or returned for credit or replacement product. Historically, expenses associated with returns have not been significant and have been recognized as incurred.

 

 6 
 

 

Royalty income is included as part of sales. We recognize royalty revenue as it is earned. The customer distribution agreements generally specify minimum royalty fees due to us during the contract period. We recognize royalty income on a straight-line basis over the term of the distribution agreement when, based on management’s analysis of sales history, the customer is not expected to meet the minimum required sales projections for the contract period. Deferred revenue on royalty income as of September 30, 2018, and December 31, 2017, was $0 and $638, respectively.

 

Cash and Cash Equivalents

 

We consider all highly liquid, short-term investments with an original maturity of three months or less to be cash equivalents. We did not hold any cash equivalents as of September 30, 2018, or December 31, 2017.

 

Investment in Securities

 

Our cost-method investment consists of an investment in a private digital multi-media technology company that totaled $300,000 at September 30, 2018 and December 31, 2017. As we owned less than 20% of that company’s stock as of each date, and no significant influence or control exists, the investment is accounted for using the cost method. We evaluated the investment for impairment and determined there was none during the periods presented.

 

Property and Equipment

 

We incur certain costs associated with the design and development of molds and dies for our contract-manufacturing segment. These costs are held as deposits on the balance sheet until the molds or dies are finished and ready for use. At that point, the costs are included as part of production equipment in property and equipment and are amortized over their useful lives. We hold title to all molds and dies used in the manufacture of products. The capitalized cost, net of accumulated depreciation, associated with molds and dies included in property and equipment at September 30, 2018, and December 31, 2017, was $12,638 and $14,357, respectively.

 

Depreciation expense is recognized in amounts equal to the cost of depreciable assets over estimated service lives. Leasehold improvements are amortized over the shorter of the life of the lease or the service life of the improvements. The straight-line method of depreciation and amortization is followed for financial reporting purposes. Maintenance, repairs, and renewals, which neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions of property and equipment are included in operating results.

 

Impairment of Long-Lived Assets

 

We review our long-lived assets, including intangibles, for impairment when events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. At each balance sheet date, we evaluate whether events and circumstances have occurred that indicate possible impairment. We use an estimate of future undiscounted net cash flows from the related asset or group of assets over their remaining life in measuring whether the assets are recoverable. We did not record expenses for the impairment of long-lived assets during the nine months ended September 30, 2018 or 2017.

 

 7 
 

 

Financial Instruments with Derivative Features

 

We do not hold or issue derivative instruments for trading purposes. However, we have financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in our balance sheet. We measure these instruments at their estimated fair value and recognize changes in their estimated fair value in results of operations during the period of change. We have estimated the fair value of these embedded derivatives using a Multi-NomialLattis model. The fair values of the derivative instruments are measured each reporting period. We recorded a loss of $0 and $8,456 on the change in fair market values of derivative liabilities during the nine months ended September 30, 2018 and 2017.

 

During the three months ended March 31, 2017, our common stock was suspended from trading. Because of this, the convertible note no longer met the criteria to bifurcate the instrument under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 815, Derivatives and Hedging. As such, we determined the underlying common stock of the instruments being accounted for as derivative liabilities had no value. As a result, the fair value of the derivative liabilities as of the date our common stock was no longer available to trade was written off to additional paid-in capital in accordance with ASC 815-15-35-4. During the three months ended September 30, 2018, we became current with its filing requirements with the SEC. However, we have not yet received clearance from FINRA for our stock to resume trading. As such, we determined the underlying common stock of the debt instruments had no value as of September 30, 2018.

 

Stock-Based Compensation

 

We have outstanding stock options to directors and employees, which are described more fully in Note 11—Stock Options and Warrants. We account for stock options in accordance with ASC 718-10, Accounting for Stock Issued to Employees, which requires the recognition of the cost of employee services received in exchanged for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. ASC 718-10 also requires the stock option compensation expense to be recognized over the period during which an employee is required to provide service in exchange for the award, typically the vesting period.

 

Stock-based employee compensation was $480 and $1,340 for the nine months ended September 30, 2018 and 2017, respectively.

 

Fair Value of Financial Instruments

 

The carrying amounts reported in the accompanying consolidated financial statements for cash, notes payable, and accounts payable approximate fair values because of the immediate or short-term maturities of these financial instruments. The carrying amounts of our debt obligations approximate fair value.

 

ASC 820-10-15, Fair Value Measurement-Overall-Scope and Scope Exceptions, defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:

 

Level 1—Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

 8 
 

 

Level 2—Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

 

Level 3—Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

Accounts payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these instruments.

 

Loss Per Share

 

Basic loss per share (EPS) is calculated by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during each period. Diluted EPS is similarly calculated, except that the weighted-average number of common shares outstanding would include common shares that may be issued subject to existing rights with dilutive potential when applicable. We had nil in potentially issuable common shares at September 30, 2018 and 2017. The potentially issuable common shares as of September 30, 2018 and 2017, were excluded from the calculation of diluted EPS because the effects were antidilutive.

 

Short-term Advances

 

We have short-term advances with various individuals. These advances are due upon demand, carry no interest, and are not collateralized. These advances are classified as short-term liabilities.

 

Recently Issued Accounting Pronouncements

 

Recently issued accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that require adoption and that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.

 

NOTE 3—GOING CONCERN AND REALIZATION OF ASSETS

 

In October 2016, we lost our ability to continue energy drink distribution, our principal source of revenue, after receiving an unfavorable ruling in our suit against Playboy Enterprises, Inc.

 

The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate our continuation as a going concern. We had a working capital deficiency of $36,332,992 and $35,750,688 as of September 30, 2018, and December 31, 2017, respectively, and a net loss of $760,141 and $1,798,042 during the nine months ended September 30, 2018 and 2017, respectively. As of September 30, 2018, and December 31, 2017, we had an accumulated deficit of $77,359,440 and $76,599,299, respectively. These conditions raise substantial doubt about our ability to continue as a going concern.

 

 9 
 

 

Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan described in the following paragraphs and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if we are unable to continue as a going concern.

 

In the coming year, our foreseeable cash requirements will relate to development of business operations and associated expenses. We may experience a cash shortfall and be required to raise additional capital.

 

Historically, we have mostly relied upon shareholder loans and advances to finance operations and growth. Management may raise additional capital by retaining net earnings, if any, or through future public or private offerings of our stock or loans from private investors, although we cannot assure that we will be able to obtain such financing. Our failure to do so could have a material and adverse effect upon us and our shareholders.

 

NOTE 4—PROPERTY AND EQUIPMENT

 

Property and equipment and estimated service lives consist of the following:

 

   September 30, 2018   December 31, 2017   Useful Life (years)
Furniture and office equipment  $177,900   $177,900   5-10
Leasehold improvements   997,714    997,714   7-10
Production equipment   2,886,267    2,886,267   5-10
Vehicles   53,209    53,209   3-7
Total   4,115,090    4,115,090    
Less: accumulated depreciation   (4,102,452)   (4,100,733)   
Property and equipment, net  $12,638   $14,357    

 

We recorded $573 and $573 of depreciation expense during the three months ended September 30, 2018 and 2017, respectively, and $1,719 and $1,719 during the nine months ended September 30, 2018 and 2017, respectively.

 

NOTE 5—RELATED-PARTY TRANSACTIONS

 

Transactions involving Officers, Directors, and Stockholders

 

In 2007, we issued a 10% promissory note to a family member of our president in exchange for $300,000. The note was due on demand after May 2008. There were no repayments made during the periods presented. At September 30, 2018, and December 31, 2017, the principal amount owing on the note was $151,833 and $151,833, respectively.

 

During the nine months ended September 30, 2018, the Company received cash advances from related parties of $58,415 and made cash repayments to related parties totaling $50,475. Additionally, a related party forgave outstanding payables of $92,000 and related parties paid expenses totaling $395,323 directly to vendors on behalf of the Company. There was $831,871 and $520,608 of short-term advances due to related parties as of September 30, 2018 and December 31, 2017, respectively. The advances are due on demand and as such included in current liabilities.

 

On March 31, 2008, we issued to this same family member, along with two other Company shareholders, promissory notes totaling $315,000 ($105,000 each). Under the terms of these three $105,000 notes, we received total proceeds of $300,000 and agreed to repay the amount received plus a 5% borrowing fee. The notes were due April 30, 2008, after which they were due on demand, with interest accruing at 12% per annum. We made no payments towards the outstanding notes during the periods presented. The principal balance owing on the notes as of September 30, 2018, and December 31, 2017, totaled $72,466 and $72,466, respectively, and are presented in liabilities from discontinued operations.

 

 10 
 

 

We have agreed to issue options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive officer. The terms of this employment agreement require us to grant options to purchase 6,000,000 shares of our stock each year, with an exercise price equal to the fair market price of our common stock as of the grant date. During the nine months ended September 30, 2018, we accrued for 6,000,000 stock options relating to this employee agreement, resulting in 66.0 million and 60.0 million accrued stock options as of September 30, 2018, and December 31, 2017, respectively. See Note 6–Other Accrued Liabilities and Note 11–Stock Options and Warrants.

 

As of September 30, 2018, and December 31, 2017, we owe our president a total of $893,000 and $898,215 in unsecured advances, of which $890,000 and $890,000 were included in liabilities from discontinued operations. Additionally, 66.0 million and 60.0 million accrued stock options, with an aggregate value at time of grant of $169,496 and $168,896, respectively, were owed as of September 30, 2018 and December 31, 2017. The advances and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by our president on these loans. 

 

NOTE 6—OTHER ACCRUED LIABILITIES

 

Accrued tax liabilities consist of delinquent payroll taxes, interest, and penalties owed by us to the Internal Revenue Service (“IRS”) and other tax entities.

 

Accrued liabilities consist of the following:

 

   September 30, 2018   December 31, 2017 
Tax liabilities  $676,184   $685,004 
Other   40,002    44,380 
Total  $716,186   $729,384 

 

Other accrued liabilities as of December 31, 2017, include a non-interest bearing payable totaling $44,380 that is due on demand. This was repaid during the nine months ended September 30, 2018.

 

Accrued payroll and compensation liabilities consist of the following:

 

   September 30, 2018   December 31, 2017 
Stock option expenses  $480,253   $479,973 
Director fees   140,000    135,000 
Bonus expenses   129,358    121,858 
Commissions   2,148    2,148 
Administrative payroll   3,450,274    3,414,258 
Total  $4,202,033   $4,153,237 

 

Stock option expenses consist of accrued employee stock option expenses. These stock options have been granted but were not issued due to the limited number of authorized and available shares (see Note 11–Stock Options and Warrants for further discussion).

 

The fair market value of the options issued during the nine months ended September 30, 2018, was $480, using the following assumptions: estimated seven-year term, estimated volatility of 567%, and a risk-free rate between 2.38%. During the three months ended March 31, 2018, we accrued for 6,000,000 stock options relating to the employee agreement with Mr. Hawatmeh. The fair market value of the options was $600, using the following assumptions: estimated seven-year term, estimated volatility of 567%, and a risk-free rate of 2.38%.

 

 11 
 

 

NOTE 7—COMMITMENTS AND CONTINGENCIES

 

Litigation and Claims

 

Various vendors, service providers, and others have asserted legal claims in previous years. These creditors generally are not actively seeking collection of amounts due them, and we have determined that the probability of realizing any loss on these claims is remote and will seek to compromise and settle at a deep discount any of such claims that are asserted for collection. These amounts are included in our current liabilities. We have not accrued any liability for claims or judgments that we have determined to be barred by the applicable statute of limitations, which generally is eight years for judgments in Utah.

 

Noble Gate

 

In September 2015, we obtained a judgment in the amount of $287,000 against Noble Gate Industrial, a former authorized distributor of the Playboy-branded energy drink. We believe the judgment is uncollectible and have not undertaken collection efforts in view of our analysis of the costs of collection as compared to any likely recovery. No gain has been recorded for the periods presented.

 

Playboy Enterprises, Inc.

 

Our wholly-owned subsidiary, Play Beverages, LLC, whose operations have now been discontinued, filed suit against Playboy Enterprises, Inc., in Cook County, Illinois, Circuit Court in October 2012 asserting numerous claims, including breach of contract and tortious interference. Playboy responded with a counterclaim of breach of contract and trademark infringement. After proceedings in October 2016, the court awarded a judgment to Playboy of $6.6 million against Play Beverages and us. The court denied our motion for a new trial and awarded Playboy treble patent infringement damages and attorney’s fees. We filed a notice of appeal in July 2017 and again in March 2018. Playboy has initiated collection efforts but has recovered no funds. We have accrued $17,205,599 as of September 30, 2018, and December 31, 2017, related to this judgment, which is included in liabilities from discontinued operations (see Note 12–Discontinued Operations ). In September 2018, the appellate court affirmed the judgment of the circuit court.

 

Redi FZE

 

During the year ended December 31, 2011, Redi FZE sued us claiming alleged breach of contract, and we counterclaimed against it. On November 2, 2011, the court issued an injunction against Redi FZE prohibiting it from selling and distributing Playboy-branded products in conjunction with its distribution agreement with us. On August 16, 2012, Redi FZE withdrew the suit, and on October 30, 2012, we were awarded a default judgment against Redi in the amount of $1,225,155. We have not collected on this judgment and are weighing the cost of collection against the likelihood of success. No gain or receivable has been recorded in the financial statements for the periods presented in connection with this case.

 

Old Dominion Freight Line

 

In December 2009, Old Dominion Freight Line filed suit against us for unpaid freight services in the amount of $30,464 and was awarded a default judgment of $33,187 in March 2010. The amount due is included in accounts payable as of September 30, 2018, and December 31, 2017, respectively.

 

RDS Touring

 

In September 2011, RDS Touring and Promotions, Inc. was awarded a default judgment of $118,426 against us. In September 2012, RDS domesticated the default judgment in the state of Utah and sought to enforce the judgment against us. We have and will continue to resist the collection efforts by RDS. We had recorded a loss equal to the judgment of $118,426, of which $18,491 was previously paid leaving $99,935 included in liabilities from discontinued operations as of September 30, 2018, and December 31, 2017.

 

 12 
 

 

Esebag

 

In July 2010, Jimmy Esebag was awarded a judgment against us for breach of contract. A judgment debtor examination of an affiliate took place in October 2013, and there have been no further recovery efforts to date. We will continue to resist the collection efforts from this judgment. We had recorded a loss equal to the judgment of $100,000, of which $40,881 was previously paid leaving $59,119 included in liabilities from discontinued operations as of September 30, 2018, and December 31, 2017, respectively.

 

General Distributors, Inc.

 

In February 2012, General Distributors, Inc. (“General”) and was awarded a default judgment of $93,856 against us. In January 2013, General domesticated the default judgment in the state of Utah and sought to enforce the judgment against the Company. We have and will continue to resist the collection efforts by General. We had recorded a loss equal to the judgment of $93,856, which is included in liabilities from discontinued operations as of September 30, 2018, and December 31, 2017.

 

Advanced Beauty Solutions

 

In connection with prior litigation with Advanced Beauty Solutions (“ABS”), it claimed nonperformance by us and filed an adversary proceeding in its bankruptcy case in the United States Bankruptcy Court. On March 17, 2009, the bankruptcy court entered judgment in favor of ABS and against us in the amount of $1,811,667, plus interest. On September 11, 2009, the bankruptcy court denied our motion to set aside the judgment.

 

On September 8, 2010, we executed an Assignment of Copyrights, thereby assigning our Copyright Registration No. TX-6-064-955, Copyright Registration No. TX-6-064-956, and Copyright to the True Ceramic Pro-Live Ops (TCPS) infomercial and related master tapes (collectively the “Copyrights”) to ABS, without reservation or exclusion, making ABS the owner of the Copyrights.

 

Despite motions, hearings, appeals, and mediation in 2011, both parties were unable to resolve their outstanding issues.

 

On March 22, 2012, we entered into a formal forbearance agreement with ABS, dated as of March 1, 2012 (the “ABS Forbearance Agreement”), whereby ABS agreed to take no further judgment enforcement actions in consideration of our payment of $25,000 upon execution, satisfaction of applicable conditions precedent, return of the trademarks and intellectual property previously conveyed by ABS to us, and our obligation to pay $1,835,000 secured by an encumbrance on all of our assets, subject and subordinate to the prior lien and encumbrance in favor of YA Global. In addition, we stipulated to an additional judgment for attorney’s fees incurred in negotiating the ABS Forbearance Agreement and related post-judgment collection efforts. The ABS Forbearance Agreement also provided that our obligation would be reduced by the greater of the amount of credit granted in the bankruptcy proceedings for the value of the intellectual property we previously conveyed to ABS and the amount received by ABS from the sale of such intellectual property to a third party during the term of the ABS Forbearance Agreement, plus the amount of any distribution to which we are entitled as a creditor of ABS, subject to other limitations.

 

In May 2013, ABS sent us a notice of default under the ABS Forbearance Agreement. Although there were some negotiations between us and ABS following the notice of default, this matter has not been resolved.

 

 13 
 

 

Our appeal of the approximately $1.8 million judgment that had been remanded in the ABS bankruptcy proceedings to conclusively determine the amount of credit due us for the conveyance of the intellectual property has been dismissed. All litigation and disputes between ABS and its affiliates, on the one hand, and us and our affiliates, on the other hand, have been dismissed.

 

We have assigned to ABS our creditor claim against the estate of ABS, to the extent of the balance due under the ABS Forbearance Agreement. Any distribution from the ABS estate in excess of the adjusted amounts due under the ABS Forbearance Agreement will be paid to us.

 

Because ABS’s lien is subordinate to liens on all of our assets in favor of Y.A. Global and/or Tekfine, LLC, ABS is unable to presently take any steps to enforce its judgment. If that changes, we would potentially face collection actions on the judgment, subject to our offset claims for the intellectual property and creditor claim.

 

We had accrued the minimum liability of $90,000, of which $45,000 has been paid leaving $45,000 due, which is included in accrued liabilities as of September 30, 2018, and December 31, 2017. Because the remaining liability is unknown and cannot be reasonably estimated, no additional amounts have been accrued.

 

Delinquent Payroll Taxes, Interest, and Penalties

 

In November 2004, the IRS accepted our amended offer in compromise (the “Offer”) to settle delinquent payroll taxes, interest, and penalties, which requires us to pay $500,000, remain current in our payment of taxes for five years, and forego claiming any net operating losses for the years 2001 through 2015 or until we pay taxes on future profits in an amount equal to the taxes of $1,455,767 waived by the Offer. In June 2013, we entered into a partial installment agreement to pay $768,526 in unpaid 2009 payroll taxes, which requires us to pay the IRS 5% of cash deposits. The monthly payments are to continue until the account balances are paid in full or until the collection statute of limitation expires on October 6, 2020. There was $367,617  due as of September 30, 2018, and December 31, 2017, of which $108,754 is included in liabilities from discontinued operations.

 

Employment Agreements

 

We engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended in September 2017, with a salary in an amount and commencement date to be determined. In July 2017, Mr. Hawatmeh resigned all positions with us to pursue other business activities, thereby effectively terminating the agreement. However, in September 2017, we reinstated Mr. Hawatmeh to his previous positions and reinstated his employment agreement. Among other things, the reinstated employment agreement: (a) grants options to purchase a minimum of 6,000,000 shares of our stock each year, with an exercise price equal to the market price of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus approved by our board; and (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5% of our earnings before interest, taxes, depreciation and amortization for the applicable quarter; (ii) bonuses equal to 1% of the net purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus (payable quarterly) equal to 1% of our gross sales of all products, net of returns and allowances.

 

 14 
 

 

In addition to the employment agreement above, we have verbal contracts with our employees that require payment of noncash compensation in a fixed number of shares. During the nine months ended September 30, 2018 and 2017, we did not grant options to purchase shares of common stock to employees due to the insufficient common shares available. We recorded expenses totaling $480 and $1,340 during the nine months ended September 30, 2018 and 2017, respectively, for employee options relating to the employment contracts of these employees.

 

NOTE 8—NOTES PAYABLE

 

Notes payable consisted of the following:

 

   September 30, 2018   December 31, 2017 
Note payable to former service provider for past due account payable (current)  $90,000   $90,000 
Note payable for settlement of debt (long term)   500,000    500,000 
Total  $590,000   $590,000 

 

There was $98,062 and $62,534 of accrued interest due on these notes as of September 30, 2018, and December 31, 2017, respectively.

 

NOTE 9—CONVERTIBLE DEBENTURES

 

Convertible debentures consisted of the following:

 

   September 30, 2018   December 31, 2017 
Convertible debenture, 5% stated interest rate, secured by all of our assets, due on October 20, 2018  $200,000   $200,000 
Convertible debenture, 5% stated interest rate, secured by all of our assets, due on April 30, 2027   2,390,528  

 

 

2,390,528 
Total  $2,590,528   $2,590,528 

 

The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $0.10 or the lowest bid price for the 20 trading days prior to conversion $nil as of September 30, 2018, and December 31, 2017).

 

As of September 30, 2018, and December 31, 2017, we had accrued interest on the convertible debentures totaling $1,235,909 and $1,144,311, of which $14,466 and $6,986 was current and $1,221,443 and $1,137,325 was long term, respectively. As of September 30, 2018 and December 31, 2017, the debentures were convertible into nil shares of our common stock.

 

NOTE 10—STOCKHOLDERS’ DEFICIT

 

We are authorized to issue up to 4,500,000,000 shares of $0.001 par value common stock. No shares were issued during the periods presented. We had a total of 4,498,891,910 common shares issued and outstanding as of September 30, 2018, and December 31, 2017.

 

 15 
 

 

NOTE 11—STOCK OPTIONS AND WARRANTS

 

Stock Incentive Plans

 

During the nine months ended September 30, 2018 and 2017, we did not grant options to purchase shares of common stock to employees or consultants. However, we have committed to issue stock options and have recorded a corresponding liability (as described in Note 6–Other Accrued Liabilities) for commitments to issue a balance of 170.6 million and 165.8 million stock options as of September 30, 2018 and December 31, 2017, respectively.

 

During the nine months ended September 30, 2018, we accrued for a net of 4,800,000 stock options (11,400,000 new grants, less rescission of 6,600,000) relating to the employment of our president and consultants. The fair market value of the accrued stock options aggregated $480, using the following assumptions: seven-year term, volatility of 567%, a risk free rate of 2.38%, and exercise price of $0.0001.

 

During the nine months ended September 30, 2017, we accrued for 13,400,000 stock options relating to the employment of our president and consultants. The fair market value of the accrued stock options aggregated $1,375, using the following assumptions: seven-year term, volatility of 567%, a risk free rate of 2.26% and exercise price of $0.0001.

 

As of September 20, 2018, we had no unrecognized compensation costs related to outstanding options that have not yet vested at year-end that would be recognized in subsequent periods. See Note 6–Other Accrued Liabilities for a description of amounts of option expenses included in accrued payroll and compensation expense.

 

NOTE 12—DISCONTINUED OPERATIONS

 

At October 21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this business are displayed as assets and liabilities from discontinued operations as of September 30, 2018, and December 31, 2017 as a result. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations for the three and nine months ended September 30, 2018 and 2017.

 

Total assets and liabilities included in discontinued operations were as follows:

 

   September 30, 2018   December 31, 2017 
Assets From Discontinued Operations:          
Cash  $122    62 
Total assets from discontinued operations  $122   $62 
           
Liabilities From Discontinued Operations:          
Accounts payable  $19,698,096   $19,641,248 
Accrued liabilities   691,436    732,548 
Accrued interest   830,192    715,409 
Accrued payroll and compensation expense   128,050    311,806 
Current maturities of long-term debt   239,085    239,085 
Related party payable   1,947,713    1,776,250 
Short-term advances payable   2,579,773    2,579,773 
Total liabilities from discontinued operations  $26,114,345   $25,996,119 

 

 16 
 

 

Net losses from discontinued operations for the three and nine months ended September 30, 2018 and 2017 were comprised of the following components:

 

  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2018   2017   2018   2017 
Net sales  $-   $-   $-   $- 
Cost of sales   -    -    -    - 
Gross profit   -    -    -    - 
                     
Operating expenses                    
Selling, general and administrative expenses   -    23,244    8,258    233,893 
Total operating expenses   -    23,244    8,258    233,893 
                     
Other expense                    
Interest expense   38,681    40,950    114,783    121,959 
Total other expense   38,681    40,950    114,783    121,959 
                     
Net loss from discontinued operations  $(38,681)  $(64,194)  $(123,041)  $(355,852)

 

NOTE 13—SUBSEQUENT EVENTS

 

We have evaluated all events occurring subsequent to the financial statements and determined there are no additional items to disclose.

 

 17 
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our condensed consolidated financial statements and notes to our financial statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors discussed elsewhere in this report.

 

Overview

 

During the first nine months of 2018 and 2017, we generated $0 and $5,000 of revenue.

 

We are seeking to commercialize consumer products and provide a mix of high- and medium-volume turnkey manufacturing services and products using various high-tech applications for leading electronics OEMs (original equipment manufacturers) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries. Our business activities will include pre-manufacturing, manufacturing, and post-manufacturing services. Our goal is to provide our customers with total manufacturing solutions through third-party providers for both new and more mature products, as well as across product generations.

 

 18 
 

 

Results of Operations for the Three Months Ended September 30, 2018, Compared to the Three Months ended September 30, 2017

 

Revenue

 

We did not generate revenue revenues during the three months ended September 30, 2018 and generated $5,000 during the three months ended September 30, 2017.

 

Operating Expenses

 

During the three months ended September 30, 2018 and 2017, selling, general, and administrative expenses were $105,068 and $91,155, respectively, representing an increase of $13,913, or 15%, in the current period. The increase in selling, general, and administrative expenses is the result of a slight increase in overall business activities in the current period.

 

Other Income and Expense

 

Other income and expenses during the three months ended September 30, 2018, consisted of $120,004 in interest expense and other income of $22,500. Other expenses during the three months ended September 30, 2017 included $120,940 for interest expense. Interest expense was approximately equal for each period because the principal amount of indebtedness and applicable interest rate were approximately the same.

 

Results of Operations for the Nine Months Ended September 30, 2018, Compared to the Nine Months ended September 30, 2017

 

Revenue

 

We did not generate revenue revenues during the nine months ended September 30, 2018 and generated $5,000 during the nine months ended September 30, 2017.

 

Operating Expenses

 

During the nine months ended September 30, 2018 and 2017, selling, general, and administrative expenses were $286,544 and $577,095, respectively, representing a decrease of $290,551, or 50%, in the current period. The decrease in selling, general, and administrative expenses is the result of our decreased overall business activities in the current period, which have been limited to minimal operating costs and professional fees associated with filing our Form 10 with the Securities and Exchange Commission.

 

Other Income and Expense

 

Other expenses during the nine months ended September 30, 2018, consisted of $373,056 in interest expense and other income of $22,500. Other expenses during the nine months ended September 30, 2017, included $361,639 for interest expense, $500,000 for losses on settlements, and $8,456 for loss on derivatives valuation. Interest expense was approximately equal for each period because the principal amount of indebtedness and applicable interest rate were approximately the same.

 

 19 
 

 

Liquidity and Capital Resources

 

We have had a history of losses from operations, as our expenses have been greater than our declining revenues, which have now ceased entirely. Our accumulated deficit was $77.4 million at September 30, 2018, compared to $76.6 million at December 31, 2017. As of September 30, 2018, and December 31, 2017, we had current assets of $18,686 and $6,233, respectively, and current liabilities of $36.4 million and $35.8 million , respectively, creating working capital deficits as of September 30, 2018, and December 31, 2017, of approximately $36.3 million and $35.8 million, respectively.

 

Operating Activities

 

We have only nominal cash or short-term assets while our current liabilities aggregate $36.4 million as of September 30, 2018. During the nine months ended September 30, 2018, we generated $4,800 of net cash in operations, comprised of a net loss of $637,100 from continuing operations, noncash items totaling $397,042 mostly comprised of expenses paid by related parties on our behalf, and changes in working capital totaling $244,858. During the nine months ended September 30, 2017, we used $99,788 of net cash in operations, comprised of a net loss of $1,442,190 from continuing operations, noncash items totaling $589,475 mostly comprised of losses on settlements of $500,000, and changes in working capital totaling $752,927.

 

Financing Activities

 

During the nine months ended September 30, 2018, financing activities generated $7,940 of cash, compared to providing $189,145 of cash during the nine months ended September 30, 2017. Cash provided by financing activities during the nine months ended September 30, 2018, consisted solely of net advances from related-party loans. Cash provided by financing activities during the nine months ended September 30, 2017, consisted of net repayments of advances from related-party loans of $8,235, repayments on a bank overdraft of $2,620 and proceeds from loans payable of $200,000.

 

Our Capital Resources and Anticipated Requirements

 

Our monthly operating costs and interest expense average approximately $84,000 per month, excluding capital expenditures. We continue to focus on generating revenue and reducing our monthly business expenses through cost reductions and operational streamlining. Currently, we do not have enough cash on hand to sustain our business operations, and we expect to access external capital resources in the near future.

 

In conjunction with our efforts to commercialize new products, we are actively seeking infusions of capital from investors. In our current financial condition, it is unlikely that we will be able to obtain additional debt financing. Even if we did acquire additional debt, we would be required to devote additional cash flow to servicing the debt and securing the debt with assets.

 

Accordingly, we are looking to obtain equity financing to meet our anticipated capital needs. We cannot assure that we will be successful in obtaining such capital. If we were to issue additional shares for debt and/or equity, this would dilute the value of our common stock and existing stockholders’ positions. We also have no authorized but unissued capital available, and we are dependent on FINRA approval of an amendment to our articles of incorporation to complete a 1,000-to-1 reverse split of our common stock, decrease our authorized common stock to 100,000,000 shares, par value $0.001, and authorize a class of 5,000,000 shares of preferred stock having such terms as the board of directors, as approved by our stockholders and board of directors in May 2015.

 

 20 
 

 

Convertible Debentures

 

We currently have an amended, restated, and consolidated secured convertible debenture with Tekfine, LLC, an unrelated entity, with a maturity date of April 30, 2027, to the extent not previously converted. The amended debenture had a total outstanding principal balance of $2.4 million, with accrued interest of $1.2 million as of September 30, 2018. In addition, we have a $200,000 convertible debenture with Tekfine, with a maturity date of October 20, 2018, unless earlier converted. The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $0.10 or the lowest bid price for the 20 trading days prior to conversion. As of the date of this report, we are unable to convert this debenture because we have insufficient authorized but unissued shares to issue upon conversion.

 

Going Concern

 

These interim unaudited financial statements have been prepared on the going concern basis, which assumes that adequate sources of financing will be obtained as required and that our assets will be realized and liabilities settled in the ordinary course of business. Accordingly, the interim unaudited financial statements do not include any adjustments related to the recoverability of assets and classification of assets and liabilities that might be necessary should we not be unable to continue as a going concern.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Critical Accounting Policies

 

We have identified the policies outlined below as critical to our business operations and an understanding of our results of operations. The list is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles in the United States, with no need for management’s judgment in their application. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results. For a detailed discussion on the application of these and other accounting policies, see the notes to our December 31, 2017 financial statements. Note that our preparation of the financial statements requires us to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period. We cannot assure that actual results will not differ from those estimates.

 

Revenue Recognition

 

We follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, the for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial statements. We recognize revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to be received in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

 21 
 

 

Royalty income is included as part of sales. We recognize royalty revenue as it is earned. The customer distribution agreements generally specify minimum royalty fees due to us during the contract period. We recognize royalty income on a straight-line basis over the term of the distribution agreement when, based on management’s analysis of sales history, the customer is not expected to meet the minimum required sales projections for the contract period.

 

Revenue on refundable customer deposits is applied to customer sales in accordance with the distribution agreement, unless the customer is in default with the terms of the distribution agreement and the deposit is forfeited. We recognize revenue on refundable deposits in the event the customer defaults on the terms of the distribution contract.

 

Shipping and handling fees are included as part of net sales. The related freight costs and supplies directly associated with shipping products to customers are included as a component of cost of goods sold.

 

Stock-Based Compensation

 

We have outstanding stock options to directors and employees. We account for our stock options in accordance with ASC 718-10, Accounting for Stock Issued to Employees, which requires the recognition of the cost of employee services received in exchanged for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. ASC 718-10 also requires the stock option compensation expense to be recognized over the period during which an employee is required to provide service in exchange for the award, typically the vesting period.

 

Income Taxes

 

We use the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on differences between financial reporting and the tax basis of assets, liabilities, the carry forward of operating losses and tax credits, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized. Research tax credits are recognized as used.

 

Fair Value of Financial Instruments

 

The carrying amounts reported in the accompanying condensed consolidated financial statements for cash, notes payable, and accounts payable approximate fair values because of the immediate or short-term maturities of these financial instruments. The carrying amounts of our debt obligations approximate fair value.

 

ASC 820-10-15, Fair Value Measurement, defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. FASB ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:

 

  Level 1:   Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
       
  Level 2:   Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
       
  Level 3:   Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

 22 
 

 

Accounts payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these instruments.

 

Recently Issued Accounting Pronouncements

 

Recently issued accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that require adoption and that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide the information required by this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

As of September 30, 2018, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive and financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures were not effective as of Septemer 30, 2018, to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the periods prescribed by U.S. Securities and Exchange Commission and that such information is accumulated and communicated to management, including our chief executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

 23 
 

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting during the nine months ended September 30, 2018, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II—OTHER INFORMATION

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as a part of this report:

 

Exhibit

Number*

  Title of Document   Location
         
Item 10   Material Contracts    
10.54   Amendment No. 1 to Secured Convertible Debenture between CirTran Corporation and Tekfine, LLC, effective April 20, 2018   (1)
         
Item 31   Rule 13a-14(a)/15d-14(a) Certifications    
31.01   Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14   This filing.
         
Item 32   Section 1350 Certifications    
32.01   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   This filing.

 

* All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. Omitted numbers in the sequence refer to documents previously filed as an exhibit.
   
(1) Incorporated by reference from Cirtran Corporation’s Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2018 filed on August 14, 2018

 

 24 
 

 

SIGNATURE PAGE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CIRTRAN CORPORATION
     
Dated: November 6, 2018 By: /s/ Iehab Hawatmeh 
    Iehab Hawatmeh, President
    Principal Executive and Financial Officer

 

 25